Prognosis and Survival Outcomes for HER2+ Early Breast Cancer

Commentary
Video

Vijayakrishna Gadi, MD, PhD, and Megan Kruse, MD, discuss clinical updates to the management of patients with HER2-positive early breast cancer.

Related Videos
A panel of 3 experts on breast cancer
A panel of 3 experts on breast cancer
Shruti Tiwari, MD
A panel of 3 experts on breast cancer
A panel of 3 experts on breast cancer
Samilia Obeng-Gyasi, MD, MPH,
Lauren E. Nye, MD
Debu Tripathy, MD
Nan Chen, MD
Debu Tripathy, MD
Related Content
breast

Neoadjuvant Pembrolizumab/Chemo, Adjuvant Pembrolizumab Boosts OS in High-Risk Early TNBC

May 28th 2024
Article
Stephen Liu, MD; Sara A. Hurvitz, MD, FACP; S. Vincent Rajkumar, MD; Sumanta Kumar Pal, MD, FASCO; Shubham Pant, MD, MBBS

Oncology Experts Preview Top Abstracts From the 2024 ASCO Annual Meeting

May 23rd 2024
Podcast
Yen-Shen Lu, MD, PhD, chief, Division of Medical Oncology, Department of Oncology, National Taiwan University Hospital; clinical professor, Department of Internal Medicine, National Taiwan University College of Medicine

Ribociclib Plus Endocrine Therapy Demonstrates PFS Advantage in HR+/HER2– Advanced Breast Cancer

May 24th 2024
Article
OncLive On Air

Revisit the OncLive On Air Episodes From February 2024

March 18th 2024
Podcast
Peter Fasching, MD

Guardant360 CDx Gains European Union Certification for Tumor Profiling in Solid Tumors

May 22nd 2024
Article
FDA

Inavolisib Receives FDA Breakthrough Therapy Designation for PIK3CA-Mutated, HR+/HER2– Breast Cancer

May 21st 2024
Article